@venturebeat.com 7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com 8 years ago
Portea Medical Announces US$37.5 Million Series B Funding Led by Accel